Abiopharma

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MEDP

Pomerantz Law Firm Announces the Filing of a Class Action Against Upstart Holdings, Inc. and Certain Officers - UPST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zoetis Inc. - ZTS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Stellantis N.V. of Class Action Lawsuit and Upcoming Deadlines - STLA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of enGene Therapeutics Inc. - ENGN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rumble Inc. - RUM

Net Asset Value(s)

Dividend in the amount of 421.03481 agorot per share, record date: 9.6.26, payment 16.6.26